Rainbow Children’s Medicare is executing a significant expansion strategy aimed at increasing its hospital bed capacity from the current 2,600 to 5,000 by the fiscal year 2032. According to an interview with The Hindu BusinessLine, Chief Executive Officer Abrarali Dalal outlined the roadmap, which includes reaching approximately 3,900 beds within the next two to three years. The company’s growth levers include digitisation, enhanced marketing, and the recruitment of additional medical staff to drive patient volumes. Dalal stated that the firm is focusing on four or five key levers to achieve these objectives, with bed expansion being the primary driver.

The financial structure of this expansion relies exclusively on internal accruals. The Hindu BusinessLine reported that the balance sheet currently holds around ₹500-550 crore, which will support the investment required for the additional 2,200 to 2,400 beds. Dalal confirmed that the company is not considering raising debt or additional liquidity to fund the project. The total investment required for the expansion is estimated at ₹2,000-2,200 crore. This approach distinguishes Rainbow from many peers who often rely on external financing for rapid scaling.

Geographically, the expansion targets a national footprint beyond its existing strongholds in Hyderabad, Bengaluru, Chennai, Delhi, and Visakhapatnam. The Hindu BusinessLine detailed that new facilities are launching in Mumbai and Pune, with Coimbatore and Gurugram lined up for future openings. Indore is expected to join the network before March 2027. Specific projects include a 385-bed hospital in Gurugram’s Sector 56 and a 100-120-bed facility in Pune for FY28. By FY30, the company expects approximately 3,800 beds to be under construction or operational, with further additions in cities like Indore, Lucknow, and Bhubaneswar.

The hospital chain reported a 27 per cent growth in the first half of the current fiscal year and projects an annual growth rate of more than 20 per cent. Dalal noted that while the industry sees substantial business through insurance and government schemes, the perception of high medical inflation is often linked to increasingly complex cases. The company is also investing in technology, including electronic medical records and AI for diagnostics, to improve efficiency. Preventive healthcare and fertility treatments are identified as key future drivers alongside the availability of trained paediatric talent.